Suppression of breast cancer cell growth by Na+/H+exchanger regulatory factor 1 (NHERF1)

Breast Cancer Research

Volumn 8, Issue 6, 2006, Pages

  Pan, Yong ^a   Wang, Lei ^a   Dai, Jia Le ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; RETINOBLASTOMA PROTEIN; SHORT HAIRPIN RNA; SODIUM PROTON EXCHANGER REGULATORY FACTOR 1; TUMOR SUPPRESSOR PROTEIN; PHOSPHOPROTEIN; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ANIMAL; BREAST TUMOR; CELL CYCLE; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; PHOSPHOPROTEINS; SODIUM-HYDROGEN ANTIPORTER;

EID: 33845509277     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1616     Document Type: Article

References (44)

1. + exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 2004, 23:8681-8687.
2. + exchanger requires a dissociable phosphoprotein cofactor. J Clin Invest 1993, 92:1781-1786.
3. + exchanger, NHE3, requires an associated-regulatory protein. PNAS 1997, 94:3010-3015.
4. Wang S, Raab RW, Schatz PJ, Guggino WB, Li M: Peptide binding consensus of the NHERF-PDZ1 domain match the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett 1998, 427:103-108.
5. Raghuram V, Mak DD, Foskett JK: Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. PNAS 2001, 98:1300-1305.
6. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL: An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 1998, 273:19797-19801.
7. + exchange. Nature 1998, 392:626-630.
8. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M: A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999, 401:286-290.
9. + exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 2000, 20:8352-8363.
10. James MF, Beauchamp RL, Manchanda N, Kazlauskas A, Ramesh V: A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration. J Cell Sci 2004, 117:2951-2961.
11. + exchanger regulatory factor. J Clin Invest 1999, 104:195-201.
12. Tang Y, Tang J, Chen Z, Trost C, Flockerzi V, Li M, Ramesh V, Zhu MX: Association of mammalian Trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF. J Biol Chem 2000, 275:37559-37564.
13. + exchanger regulatory factor 2. J Biol Chem 2000, 275:16632-16637.
14. + exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem 1999, 274:24328-24334.
15. Mohler PJ, Kreda SM, Boucher RC, Sudol M, Stutts MJ, Milgram SL: Yes-associated protein 65 localizes p62c-Yes to the apical compartment of airway epithelia by association with EBP50. J Cell Biol 1999, 147:879-890.
16. Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S: EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38:178-186.
17. + exchanger, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 1998, 273:1273-1276.
18. Reczek D, Berryman M, Bretscher A: Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 1997, 139:169-179.
19. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, et al.: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993, 363:515-521.
20. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al.: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993, 72:791-800.
21. +-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF. Biochem J 2003, 376:505-510.
22. Voltz JW, Weinman EJ, Shenolikar S: Expanding the role of NHERF, a PDZ-domain containing protein adaptor, to growth regulation. Oncogene 2001, 20:6309-6314.
23. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Macher ER: Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994, 3:347-350.
24. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS: Estrogen receptor regulation of the Na+/H+ exchanger regulatory factor. Endocrinology 1999, 140:2976-2982.
25. + exchanger regulatory factor/ ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Mol Endocrinol 2002, 16:1828-1839.
26. Wang L, Pan Y, Dai JL: Evidence of prooncogenic activity of MKK4 in breast and pancreatic tumors. Oncogene 2004, 23:5978-5985.
27. Yang G, Cai KQ, Thompson-Lanza JA, Bast RC Jr, Liu J: Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression. J Biol Chem 2004, 279:4339-4345.
28. Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL: Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 2003, 63:4724-4730.
29. Ellison G, Klinowska T, Westwood RFR, Docter E, French T, Fox JC: Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002, 55:294-299.
30. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235.
31. Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, Yu D: Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004, 64:3479-3485.
32. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE, Cohen WA, Ramesh V, Louis DN: NHERF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 2001, 158:57-62.
33. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, et al.: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. PNAS 2004, 101:1892-1897.
34. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677.
35. + exchanger regulatory factor-1 by Cdc2 kinase. J Biol Chem 2001, 276:41559-41565.
36. Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, Weinberg RA: Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J 1994, 13:118-127.
37. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992, 70:993-1006.
38. Bortner DM, Rosenberg MP: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 1997, 17:453-459.
39. Hunt KK, Keyomarsi K: Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol 2005, 15:319-326.
40. Weinman EJ, Steplock D, Zhang X, Akhter S, Shenolikar S: Molecular cloning of the cDNA and promoter sequences for the mouse sodium-hydrogen exchanger regulatory factor. Biochem Biophys Acta 1999, 1447:71-76.
41. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ: Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. PNAS 2002, 99:11470-11475.
42. Coopman PJ, Do MTH, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, et al.: The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000, 406:742-747.
43. Yuan YF, Mendez R, Sahin A, Dai JL: Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001, 61:5558-5561.
44. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM: PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 2006, 25:910-920.